These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 30683885)

  • 1. FGL2 promotes tumor progression in the CNS by suppressing CD103
    Yan J; Zhao Q; Gabrusiewicz K; Kong LY; Xia X; Wang J; Ott M; Xu J; Davis RE; Huo L; Rao G; Sun SC; Watowich SS; Heimberger AB; Li S
    Nat Commun; 2019 Jan; 10(1):448. PubMed ID: 30683885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.
    Yan J; Kong LY; Hu J; Gabrusiewicz K; Dibra D; Xia X; Heimberger AB; Li S
    J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 25971300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GM-CSF increases cross-presentation and CD103 expression by mouse CD8⁺ spleen dendritic cells.
    Zhan Y; Carrington EM; van Nieuwenhuijze A; Bedoui S; Seah S; Xu Y; Wang N; Mintern JD; Villadangos JA; Wicks IP; Lew AM
    Eur J Immunol; 2011 Sep; 41(9):2585-95. PubMed ID: 21660938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of CD103 (αE integrin) expression in human dendritic cells by retinoic acid and Toll-like receptor ligands.
    Roe MM; Swain S; Sebrell TA; Sewell MA; Collins MM; Perrino BA; Smith PD; Smythies LE; Bimczok D
    J Leukoc Biol; 2017 May; 101(5):1169-1180. PubMed ID: 28087652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RCC2 promotes proliferation and radio-resistance in glioblastoma via activating transcription of DNMT1.
    Yu H; Zhang S; Ibrahim AN; Wang J; Deng Z; Wang M
    Biochem Biophys Res Commun; 2019 Aug; 516(3):999-1006. PubMed ID: 31277942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Directed antigen targeting in vivo identifies a role for CD103+ dendritic cells in both tolerogenic and immunogenic T-cell responses.
    Semmrich M; Plantinga M; Svensson-Frej M; Uronen-Hansson H; Gustafsson T; Mowat AM; Yrlid U; Lambrecht BN; Agace WW
    Mucosal Immunol; 2012 Mar; 5(2):150-60. PubMed ID: 22166938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Butyrate and retinoic acid imprint mucosal-like dendritic cell development synergistically from bone marrow cells.
    Qiang Y; Xu J; Yan C; Jin H; Xiao T; Yan N; Zhou L; An H; Zhou X; Shao Q; Xia S
    Clin Exp Immunol; 2017 Sep; 189(3):290-297. PubMed ID: 28542882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective and efficient generation of functional Batf3-dependent CD103+ dendritic cells from mouse bone marrow.
    Mayer CT; Ghorbani P; Nandan A; Dudek M; Arnold-Schrauf C; Hesse C; Berod L; Stüve P; Puttur F; Merad M; Sparwasser T
    Blood; 2014 Nov; 124(20):3081-91. PubMed ID: 25100743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into the role of the aryl hydrocarbon receptor in the function of CD11c⁺ cells during respiratory viral infection.
    Jin GB; Winans B; Martin KC; Paige Lawrence B
    Eur J Immunol; 2014 Jun; 44(6):1685-1698. PubMed ID: 24519489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GM-CSF-dependent, CD103+ dermal dendritic cells play a critical role in Th effector cell differentiation after subcutaneous immunization.
    King IL; Kroenke MA; Segal BM
    J Exp Med; 2010 May; 207(5):953-61. PubMed ID: 20421390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrinsically de-sialylated CD103(+) CD8 T cells mediate beneficial anti-glioma immune responses.
    Jouanneau E; Black KL; Veiga L; Cordner R; Goverdhana S; Zhai Y; Zhang XX; Panwar A; Mardiros A; Wang H; Gragg A; Zandian M; Irvin DK; Wheeler CJ
    Cancer Immunol Immunother; 2014 Sep; 63(9):911-24. PubMed ID: 24893855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted deletion of FGL2 leads to increased early viral replication and enhanced adaptive immunity in a murine model of acute viral hepatitis caused by LCMV WE.
    Khattar R; Luft O; Yavorska N; Shalev I; Phillips MJ; Adeyi O; Gao D; Bartczak A; Urbanellis P; Shyu W; Zhang J; Manuel J; Levy GA; Selzner N
    PLoS One; 2013; 8(10):e72309. PubMed ID: 24146739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Batf3-dependent CD103+ dendritic cells are major producers of IL-12 that drive local Th1 immunity against Leishmania major infection in mice.
    Martínez-López M; Iborra S; Conde-Garrosa R; Sancho D
    Eur J Immunol; 2015 Jan; 45(1):119-29. PubMed ID: 25312824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proinflammatory microenvironments within the intestine regulate the differentiation of tissue-resident CD8⁺ T cells responding to infection.
    Bergsbaken T; Bevan MJ
    Nat Immunol; 2015 Apr; 16(4):406-14. PubMed ID: 25706747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD103- and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells.
    del Rio ML; Rodriguez-Barbosa JI; Kremmer E; Förster R
    J Immunol; 2007 Jun; 178(11):6861-6. PubMed ID: 17513734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The closely related CD103+ dendritic cells (DCs) and lymphoid-resident CD8+ DCs differ in their inflammatory functions.
    Jiao Z; Bedoui S; Brady JL; Walter A; Chopin M; Carrington EM; Sutherland RM; Nutt SL; Zhang Y; Ko HJ; Wu L; Lew AM; Zhan Y
    PLoS One; 2014; 9(3):e91126. PubMed ID: 24637385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal effect of CD103 expression on the control of a chronic antiviral immune response.
    Fousteri G; Dave A; Juntti T; Morin B; McClure M; Von Herrath M
    Viral Immunol; 2010 Jun; 23(3):285-94. PubMed ID: 20565292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing.
    Johansson-Lindbom B; Svensson M; Pabst O; Palmqvist C; Marquez G; Förster R; Agace WW
    J Exp Med; 2005 Oct; 202(8):1063-73. PubMed ID: 16216890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p38 MAPK signaling mediates retinoic acid-induced CD103 expression in human dendritic cells.
    Roe MM; Hashimi M; Swain S; Woo KM; Bimczok D
    Immunology; 2020 Nov; 161(3):230-244. PubMed ID: 32737889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble fibrinogen-like protein 2/fibroleukin exhibits immunosuppressive properties: suppressing T cell proliferation and inhibiting maturation of bone marrow-derived dendritic cells.
    Chan CW; Kay LS; Khadaroo RG; Chan MW; Lakatoo S; Young KJ; Zhang L; Gorczynski RM; Cattral M; Rotstein O; Levy GA
    J Immunol; 2003 Apr; 170(8):4036-44. PubMed ID: 12682232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.